NOMURA HOLDINGS INC

Position in GOSS — Gossamer Bio, Inc.

CIK 1163653 TOKYO, M0

Back to GOSS Full portfolio

Position in GOSS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

-$49,600 QoQ

Shares Held

-100.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

6 quarters on record

Common Shares in GOSS Over Time

Shares Held

Position Value (USD)

Derivatives in GOSS

reported options exposure · as of Mar 31, 2026

CallValue

CallShares

PutValue

$24,642

PutShares

74,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NOMURA HOLDINGS INC holds $218,808,046 across 46 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	402,192	$31,889,803
2	BBIO	BridgeBio Pharma, Inc.	327,475	$24,390,338
3	LGND	Ligand Pharmaceuticals Inc	61,938	$19,577,982
4	AUPH	Aurinia Pharmaceuticals Inc.	978,602	$16,606,875
5	HRMY	Harmony Biosciences Holdings, Inc.	417,932	$15,216,904
6	VRTX	Vertex Pharmaceuticals Inc / Ma	29,198	$14,503,522
7	OABI	OmniAb, Inc.	5,028,160	$12,369,273
8	REGN	Regeneron Pharmaceuticals, Inc.	14,320	$8,929,092

All Filings in GOSS

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$24,642	74,900	+24.8%	Put	Defined	2026-05-15
2025-12-31	$115,010	37,100	—	Call	Defined	2026-02-17
2025-12-31	$49,600	16,000	-60.0%	Shares	Defined	2026-02-17
2025-12-31	$186,000	60,000	—	Put	Defined	2026-02-17
2024-06-30	$36,040	40,000	-45.9%	Shares	Defined	2024-08-14
2021-03-31	$684,500	74,000	-10.2%	Shares	Sole	2021-05-17
2020-12-31	$796,808	82,400	+6.7%	Shares	Sole	2021-02-16
2020-09-30	$958,039	77,199	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.